Jamie E. Chaft, Patrick M. Forde, Kellie Nicole Smith, et al. Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers. J Clin Oncol 35, 2017 (suppl; abstr 8508).
Neoadjuvant pertuzumab plus trastuzumab met of zonder chemotherapie: 5-jaarsoverlevingsdata
jun 2022 | Borstkanker